

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.89919593 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.89919593 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.80087747 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.80087747 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.20805946 |
| 6 | glyoxylate metabolic process (GO:0046487) | 5.91348325 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.67329611 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.61160585 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.61160585 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.61160585 |
| 11 | lysine metabolic process (GO:0006553) | 5.57140767 |
| 12 | lysine catabolic process (GO:0006554) | 5.57140767 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.53026719 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 5.31768525 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.31290132 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.30603633 |
| 17 | cysteine metabolic process (GO:0006534) | 5.30125241 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.20228750 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.11343751 |
| 20 | urea cycle (GO:0000050) | 4.91994916 |
| 21 | urea metabolic process (GO:0019627) | 4.91994916 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 4.83232651 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.83013162 |
| 24 | amino-acid betaine metabolic process (GO:0006577) | 4.78486169 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 4.77437550 |
| 26 | regulation of triglyceride catabolic process (GO:0010896) | 4.62655824 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.58791336 |
| 28 | protein carboxylation (GO:0018214) | 4.58791336 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 4.57699643 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.55531068 |
| 31 | aromatic amino acid family metabolic process (GO:0009072) | 4.54649160 |
| 32 | regulation of fibrinolysis (GO:0051917) | 4.50832198 |
| 33 | cellular ketone body metabolic process (GO:0046950) | 4.49539838 |
| 34 | bile acid metabolic process (GO:0008206) | 4.47958122 |
| 35 | complement activation, alternative pathway (GO:0006957) | 4.46799054 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.44560107 |
| 37 | alpha-amino acid catabolic process (GO:1901606) | 4.42038292 |
| 38 | regulation of protein activation cascade (GO:2000257) | 4.40732022 |
| 39 | glycine metabolic process (GO:0006544) | 4.28348823 |
| 40 | ethanol oxidation (GO:0006069) | 4.22911441 |
| 41 | triglyceride homeostasis (GO:0070328) | 4.22780166 |
| 42 | acylglycerol homeostasis (GO:0055090) | 4.22780166 |
| 43 | short-chain fatty acid metabolic process (GO:0046459) | 4.21346514 |
| 44 | serine family amino acid metabolic process (GO:0009069) | 4.21145512 |
| 45 | fatty acid beta-oxidation (GO:0006635) | 4.19119018 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.18429615 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.18429615 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.18429615 |
| 49 | negative regulation of sterol transport (GO:0032372) | 4.17751161 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 4.17751161 |
| 51 | reverse cholesterol transport (GO:0043691) | 4.16399773 |
| 52 | cellular amino acid catabolic process (GO:0009063) | 4.15816302 |
| 53 | tyrosine metabolic process (GO:0006570) | 4.15532396 |
| 54 | regulation of complement activation (GO:0030449) | 4.12114943 |
| 55 | aspartate family amino acid catabolic process (GO:0009068) | 4.08893120 |
| 56 | phospholipid efflux (GO:0033700) | 4.08015065 |
| 57 | drug transmembrane transport (GO:0006855) | 4.05080510 |
| 58 | serine family amino acid biosynthetic process (GO:0009070) | 4.04203391 |
| 59 | 2-oxoglutarate metabolic process (GO:0006103) | 4.03518189 |
| 60 | fatty acid oxidation (GO:0019395) | 4.00664994 |
| 61 | cellular modified amino acid catabolic process (GO:0042219) | 3.99653724 |
| 62 | coenzyme catabolic process (GO:0009109) | 3.98972879 |
| 63 | benzene-containing compound metabolic process (GO:0042537) | 3.98453378 |
| 64 | plasma lipoprotein particle clearance (GO:0034381) | 3.98216939 |
| 65 | drug catabolic process (GO:0042737) | 3.96296976 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 3.95537126 |
| 67 | acetyl-CoA metabolic process (GO:0006084) | 3.95416565 |
| 68 | lipid oxidation (GO:0034440) | 3.92536888 |
| 69 | valine metabolic process (GO:0006573) | 3.92397942 |
| 70 | urate metabolic process (GO:0046415) | 3.91492989 |
| 71 | carnitine metabolic process (GO:0009437) | 3.88860006 |
| 72 | ketone body metabolic process (GO:1902224) | 3.87840144 |
| 73 | fatty acid catabolic process (GO:0009062) | 3.87269097 |
| 74 | aldehyde catabolic process (GO:0046185) | 3.85684924 |
| 75 | glutamate metabolic process (GO:0006536) | 3.85193879 |
| 76 | cellular glucuronidation (GO:0052695) | 3.84712108 |
| 77 | carboxylic acid catabolic process (GO:0046395) | 3.84504659 |
| 78 | organic acid catabolic process (GO:0016054) | 3.84504659 |
| 79 | monocarboxylic acid catabolic process (GO:0072329) | 3.82917939 |
| 80 | amine catabolic process (GO:0009310) | 3.81794769 |
| 81 | cellular biogenic amine catabolic process (GO:0042402) | 3.81794769 |
| 82 | imidazole-containing compound metabolic process (GO:0052803) | 3.73919984 |
| 83 | bile acid and bile salt transport (GO:0015721) | 3.73253135 |
| 84 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.70158097 |
| 85 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.61926689 |
| 86 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.61926689 |
| 87 | plasma lipoprotein particle assembly (GO:0034377) | 3.58888198 |
| 88 | positive regulation of lipid catabolic process (GO:0050996) | 3.57658323 |
| 89 | cholesterol efflux (GO:0033344) | 3.56056441 |
| 90 | response to nitrosative stress (GO:0051409) | 3.53690050 |
| 91 | branched-chain amino acid catabolic process (GO:0009083) | 3.52894420 |
| 92 | arginine metabolic process (GO:0006525) | 3.52500708 |
| 93 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.51826322 |
| 94 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.51421218 |
| 95 | regulation of cholesterol homeostasis (GO:2000188) | 3.50175966 |
| 96 | cofactor catabolic process (GO:0051187) | 3.50059414 |
| 97 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.47216795 |
| 98 | uronic acid metabolic process (GO:0006063) | 3.45284864 |
| 99 | glucuronate metabolic process (GO:0019585) | 3.45284864 |
| 100 | drug transport (GO:0015893) | 3.45249947 |
| 101 | cholesterol homeostasis (GO:0042632) | 3.45001831 |
| 102 | branched-chain amino acid metabolic process (GO:0009081) | 3.43368398 |
| 103 | NADH metabolic process (GO:0006734) | 3.22141586 |
| 104 | immunoglobulin mediated immune response (GO:0016064) | 3.12111620 |
| 105 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.05121271 |
| 106 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.02095637 |
| 107 | epoxygenase P450 pathway (GO:0019373) | 2.91200706 |
| 108 | angiotensin maturation (GO:0002003) | 2.86621396 |
| 109 | deoxyribonucleotide catabolic process (GO:0009264) | 2.79991854 |
| 110 | pinocytosis (GO:0006907) | 2.78921417 |
| 111 | glycosphingolipid catabolic process (GO:0046479) | 2.78635135 |
| 112 | pentose-phosphate shunt (GO:0006098) | 2.78361099 |
| 113 | GDP-mannose metabolic process (GO:0019673) | 2.77934638 |
| 114 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.71221134 |
| 115 | xenobiotic catabolic process (GO:0042178) | 2.69163300 |
| 116 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.63897800 |
| 117 | deoxyribose phosphate catabolic process (GO:0046386) | 2.62358667 |
| 118 | cellular response to arsenic-containing substance (GO:0071243) | 2.62208107 |
| 119 | response to peptidoglycan (GO:0032494) | 2.61454572 |
| 120 | pentose metabolic process (GO:0019321) | 2.61094735 |
| 121 | fructose metabolic process (GO:0006000) | 2.60640069 |
| 122 | glycolipid catabolic process (GO:0019377) | 2.57856314 |
| 123 | daunorubicin metabolic process (GO:0044597) | 2.54877097 |
| 124 | polyketide metabolic process (GO:0030638) | 2.54877097 |
| 125 | doxorubicin metabolic process (GO:0044598) | 2.54877097 |
| 126 | iron-sulfur cluster assembly (GO:0016226) | 2.54670532 |
| 127 | metallo-sulfur cluster assembly (GO:0031163) | 2.54670532 |
| 128 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.53991904 |
| 129 | oxaloacetate metabolic process (GO:0006107) | 2.53839939 |
| 130 | NADPH regeneration (GO:0006740) | 2.51752244 |
| 131 | neutrophil activation involved in immune response (GO:0002283) | 2.51660443 |
| 132 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.50926299 |
| 133 | amyloid precursor protein catabolic process (GO:0042987) | 2.49681304 |
| 134 | blood coagulation, intrinsic pathway (GO:0007597) | 2.49144490 |
| 135 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.47667937 |
| 136 | regulation of superoxide anion generation (GO:0032928) | 2.44901585 |
| 137 | purine nucleotide salvage (GO:0032261) | 2.41933127 |
| 138 | barbed-end actin filament capping (GO:0051016) | 2.37948146 |
| 139 | oxidative phosphorylation (GO:0006119) | 2.37531931 |
| 140 | glycoside metabolic process (GO:0016137) | 2.36486554 |
| 141 | nucleotide salvage (GO:0043173) | 2.35908805 |
| 142 | acute-phase response (GO:0006953) | 2.35309640 |
| 143 | fibrinolysis (GO:0042730) | 2.35300122 |
| 144 | drug metabolic process (GO:0017144) | 2.33793905 |
| 145 | glucose catabolic process (GO:0006007) | 2.33187157 |
| 146 | cellular response to zinc ion (GO:0071294) | 2.32555120 |
| 147 | quinone biosynthetic process (GO:1901663) | 2.32275986 |
| 148 | protein maturation by protein folding (GO:0022417) | 2.31993512 |
| 149 | peptide catabolic process (GO:0043171) | 2.31786264 |
| 150 | lipoxygenase pathway (GO:0019372) | 2.31537712 |
| 151 | amino sugar catabolic process (GO:0046348) | 2.31052646 |
| 152 | B cell mediated immunity (GO:0019724) | 2.30010324 |
| 153 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.28787027 |
| 154 | positive regulation of antigen processing and presentation (GO:0002579) | 2.28620971 |
| 155 | quinone metabolic process (GO:1901661) | 2.27469161 |
| 156 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.23226565 |
| 157 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.22818011 |
| 158 | oligosaccharide catabolic process (GO:0009313) | 2.22707799 |
| 159 | mature B cell differentiation involved in immune response (GO:0002313) | 2.21492337 |
| 160 | ethanol metabolic process (GO:0006067) | 2.21253251 |
| 161 | NADP metabolic process (GO:0006739) | 2.20680755 |
| 162 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.20669899 |
| 163 | UV protection (GO:0009650) | 2.20142838 |
| 164 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.19859076 |
| 165 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.18659644 |
| 166 | omega-hydroxylase P450 pathway (GO:0097267) | 2.18420660 |
| 167 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.18320116 |
| 168 | response to interferon-beta (GO:0035456) | 2.17534218 |
| 169 | heme metabolic process (GO:0042168) | 2.17200203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.46993236 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.63894894 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.08463177 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.89943660 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.61139193 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.75286125 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.37772377 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.76384059 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.64150496 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.37532812 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.85609891 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.44987113 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.37603541 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.30648662 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.7409266 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.91014893 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.90281442 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.86186306 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.85906232 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.82736325 |
| 21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.79122095 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.77849836 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.69326577 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.66128814 |
| 25 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.58479226 |
| 26 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.56725641 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.56300067 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.55236522 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54711932 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.49129971 |
| 31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.48317488 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41239440 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40505739 |
| 34 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.33567751 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32878496 |
| 36 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.32396040 |
| 37 | P68_20966046_ChIP-Seq_HELA_Human | 1.32354826 |
| 38 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32164155 |
| 39 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31716820 |
| 40 | MYC_22102868_ChIP-Seq_BL_Human | 1.31527172 |
| 41 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.30779288 |
| 42 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30164777 |
| 43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29095820 |
| 44 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27078575 |
| 45 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.26619245 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.25115121 |
| 47 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.24049235 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22992485 |
| 49 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22488538 |
| 50 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.22304270 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22251487 |
| 52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.21766916 |
| 53 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20989583 |
| 54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20719346 |
| 55 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.20389794 |
| 56 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20330553 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20261215 |
| 58 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.20214576 |
| 59 | MAF_26560356_Chip-Seq_TH1_Human | 1.17718153 |
| 60 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16286219 |
| 61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15758988 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14617715 |
| 63 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.14392933 |
| 64 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.14335578 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13691826 |
| 66 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.13064981 |
| 67 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.12834535 |
| 68 | MAF_26560356_Chip-Seq_TH2_Human | 1.12252717 |
| 69 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.11984699 |
| 70 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.11677555 |
| 71 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.11604509 |
| 72 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.11287153 |
| 73 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11275788 |
| 74 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.09779958 |
| 75 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.08736472 |
| 76 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.08423752 |
| 77 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.07422875 |
| 78 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.05278140 |
| 79 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.05204931 |
| 80 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.03953058 |
| 81 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03454067 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03414340 |
| 83 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.02664592 |
| 84 | SA1_27219007_Chip-Seq_Bcells_Human | 1.02608143 |
| 85 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01720178 |
| 86 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01244343 |
| 87 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.00731383 |
| 88 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.00470439 |
| 89 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.99637552 |
| 90 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99304561 |
| 91 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.98627553 |
| 92 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98133864 |
| 93 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.97819542 |
| 94 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.97360944 |
| 95 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.93095920 |
| 96 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92965556 |
| 97 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.90659770 |
| 98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89896494 |
| 99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.84612239 |
| 100 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.82565065 |
| 101 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.82296296 |
| 102 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.81343286 |
| 103 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80384899 |
| 104 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.80306138 |
| 105 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.79380378 |
| 106 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78252008 |
| 107 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76382276 |
| 108 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.76147470 |
| 109 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.73814838 |
| 110 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.71316560 |
| 111 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.70604833 |
| 112 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.70314824 |
| 113 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.68503915 |
| 114 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.68382898 |
| 115 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.67452348 |
| 116 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.65987233 |
| 117 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.65780226 |
| 118 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64262893 |
| 119 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.63794566 |
| 120 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.63674461 |
| 121 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63546425 |
| 122 | AR_20517297_ChIP-Seq_VCAP_Human | 0.63177038 |
| 123 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.62300837 |
| 124 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.60929291 |
| 125 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.59921989 |
| 126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.59805708 |
| 127 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.57552135 |
| 128 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.57386442 |
| 129 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.56923474 |
| 130 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.56565933 |
| 131 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.55588965 |
| 132 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55514259 |
| 133 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.55361529 |
| 134 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.55136616 |
| 135 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.54972586 |
| 136 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.54894131 |
| 137 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.54624307 |
| 138 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.53498080 |
| 139 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52650076 |
| 140 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52211177 |
| 141 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.51415735 |
| 142 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.51323398 |
| 143 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.51257088 |
| 144 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.51257088 |
| 145 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.51114338 |
| 146 | GATA1_19941826_ChIP-Seq_K562_Human | 0.50863495 |
| 147 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.50792100 |
| 148 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.49696062 |
| 149 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.48939532 |
| 150 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.48450570 |
| 151 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.48267546 |
| 152 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.48073976 |
| 153 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.48012091 |
| 154 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.47942317 |
| 155 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47920656 |
| 156 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.47586091 |
| 157 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.47578290 |
| 158 | P300_27268052_Chip-Seq_Bcells_Human | 0.47575136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.85972207 |
| 2 | MP0005360_urolithiasis | 7.24398084 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.76933984 |
| 4 | MP0005365_abnormal_bile_salt | 5.69934256 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.59373077 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.37996398 |
| 7 | MP0003252_abnormal_bile_duct | 3.61820580 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.25798531 |
| 9 | MP0009840_abnormal_foam_cell | 3.10159861 |
| 10 | MP0005332_abnormal_amino_acid | 2.98451063 |
| 11 | MP0003195_calcinosis | 2.82682470 |
| 12 | MP0005083_abnormal_biliary_tract | 2.76708899 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.55795589 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.34596195 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.28152683 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.26885041 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.16838195 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.16234428 |
| 19 | MP0009785_altered_susceptibility_to | 2.14351527 |
| 20 | MP0000609_abnormal_liver_physiology | 2.09781578 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.03547890 |
| 22 | MP0005025_abnormal_response_to | 1.96171921 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.95354394 |
| 24 | MP0002419_abnormal_innate_immunity | 1.88868448 |
| 25 | MP0003303_peritoneal_inflammation | 1.83349366 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.75903727 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.75375689 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.74839231 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.70960311 |
| 30 | MP0003186_abnormal_redox_activity | 1.68670548 |
| 31 | MP0001764_abnormal_homeostasis | 1.68476525 |
| 32 | MP0001790_abnormal_immune_system | 1.65116365 |
| 33 | MP0005387_immune_system_phenotype | 1.65116365 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.64214792 |
| 35 | MP0006082_CNS_inflammation | 1.58643572 |
| 36 | MP0006036_abnormal_mitochondrial_physio | 1.54599298 |
| 37 | MP0003868_abnormal_feces_composition | 1.46046793 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.45995154 |
| 39 | MP0009278_abnormal_bone_marrow | 1.44850397 |
| 40 | MP0001800_abnormal_humoral_immune | 1.44149690 |
| 41 | MP0002723_abnormal_immune_serum | 1.43127322 |
| 42 | MP0000343_altered_response_to | 1.42350345 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.41710214 |
| 44 | MP0000685_abnormal_immune_system | 1.39069896 |
| 45 | MP0005671_abnormal_response_to | 1.36735251 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.36220887 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.33206083 |
| 48 | MP0005636_abnormal_mineral_homeostasis | 1.31928965 |
| 49 | MP0005166_decreased_susceptibility_to | 1.31692302 |
| 50 | MP0002420_abnormal_adaptive_immunity | 1.29410145 |
| 51 | MP0001819_abnormal_immune_cell | 1.29408971 |
| 52 | MP0009697_abnormal_copulation | 1.25451380 |
| 53 | MP0005451_abnormal_body_composition | 1.24721274 |
| 54 | MP0005670_abnormal_white_adipose | 1.21427158 |
| 55 | MP0000598_abnormal_liver_morphology | 1.20601603 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.19114625 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.19114625 |
| 58 | MP0008260_abnormal_autophagy | 1.18548689 |
| 59 | MP0002837_dystrophic_cardiac_calcinosis | 1.16218710 |
| 60 | MP0000858_altered_metastatic_potential | 1.14041233 |
| 61 | MP0004043_abnormal_pH_regulation | 1.12109197 |
| 62 | MP0003705_abnormal_hypodermis_morpholog | 1.11909172 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.10354902 |
| 64 | MP0009764_decreased_sensitivity_to | 0.99757420 |
| 65 | MP0003011_delayed_dark_adaptation | 0.99710336 |
| 66 | MP0009763_increased_sensitivity_to | 0.99195014 |
| 67 | MP0008469_abnormal_protein_level | 0.98715858 |
| 68 | MP0000490_abnormal_crypts_of | 0.98690923 |
| 69 | MP0002405_respiratory_system_inflammati | 0.98676955 |
| 70 | MP0004130_abnormal_muscle_cell | 0.98259676 |
| 71 | MP0000716_abnormal_immune_system | 0.97096180 |
| 72 | MP0004510_myositis | 0.96638324 |
| 73 | MP0001756_abnormal_urination | 0.96240799 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 0.94184519 |
| 75 | MP0009642_abnormal_blood_homeostasis | 0.94089667 |
| 76 | MP0000678_abnormal_parathyroid_gland | 0.93897079 |
| 77 | MP0005084_abnormal_gallbladder_morpholo | 0.93865211 |
| 78 | MP0005220_abnormal_exocrine_pancreas | 0.93705967 |
| 79 | MP0002078_abnormal_glucose_homeostasis | 0.92735792 |
| 80 | MP0000689_abnormal_spleen_morphology | 0.90214897 |
| 81 | MP0005647_abnormal_sex_gland | 0.89401265 |
| 82 | MP0004947_skin_inflammation | 0.87020831 |
| 83 | MP0002429_abnormal_blood_cell | 0.86597324 |
| 84 | MP0002971_abnormal_brown_adipose | 0.86308584 |
| 85 | MP0006035_abnormal_mitochondrial_morpho | 0.85556973 |
| 86 | MP0005165_increased_susceptibility_to | 0.84414509 |
| 87 | MP0005266_abnormal_metabolism | 0.83906182 |
| 88 | MP0008004_abnormal_stomach_pH | 0.83673077 |
| 89 | MP0005376_homeostasis/metabolism_phenot | 0.83167494 |
| 90 | MP0002722_abnormal_immune_system | 0.80468741 |
| 91 | MP0000604_amyloidosis | 0.79883482 |
| 92 | MP0005666_abnormal_adipose_tissue | 0.79752581 |
| 93 | MP0002398_abnormal_bone_marrow | 0.79382800 |
| 94 | MP0005408_hypopigmentation | 0.78607851 |
| 95 | MP0010368_abnormal_lymphatic_system | 0.78573710 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.78259382 |
| 97 | MP0001849_ear_inflammation | 0.77523595 |
| 98 | MP0003866_abnormal_defecation | 0.76467127 |
| 99 | MP0000681_abnormal_thyroid_gland | 0.75778548 |
| 100 | MP0001873_stomach_inflammation | 0.75560967 |
| 101 | MP0005535_abnormal_body_temperature | 0.74478876 |
| 102 | MP0005334_abnormal_fat_pad | 0.74424489 |
| 103 | MP0003763_abnormal_thymus_physiology | 0.73787814 |
| 104 | MP0003279_aneurysm | 0.72267349 |
| 105 | MP0001542_abnormal_bone_strength | 0.72023477 |
| 106 | MP0002876_abnormal_thyroid_physiology | 0.71140219 |
| 107 | MP0002254_reproductive_system_inflammat | 0.70890843 |
| 108 | MP0001663_abnormal_digestive_system | 0.70882471 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.67309318 |
| 110 | MP0004147_increased_porphyrin_level | 0.65813128 |
| 111 | MP0005330_cardiomyopathy | 0.65259799 |
| 112 | MP0003724_increased_susceptibility_to | 0.60818283 |
| 113 | MP0001661_extended_life_span | 0.59865729 |
| 114 | MP0001765_abnormal_ion_homeostasis | 0.57643654 |
| 115 | MP0005058_abnormal_lysosome_morphology | 0.56923677 |
| 116 | MP0005464_abnormal_platelet_physiology | 0.55231119 |
| 117 | MP0002928_abnormal_bile_duct | 0.53860445 |
| 118 | MP0005448_abnormal_energy_balance | 0.53057452 |
| 119 | MP0001853_heart_inflammation | 0.52767192 |
| 120 | MP0000230_abnormal_systemic_arterial | 0.51294827 |
| 121 | MP0009053_abnormal_anal_canal | 0.49768862 |
| 122 | MP0002970_abnormal_white_adipose | 0.48987326 |
| 123 | MP0009115_abnormal_fat_cell | 0.48770256 |
| 124 | MP0003953_abnormal_hormone_level | 0.47312244 |
| 125 | MP0002269_muscular_atrophy | 0.47167735 |
| 126 | MP0003638_abnormal_response/metabolism_ | 0.47034918 |
| 127 | MP0003646_muscle_fatigue | 0.45193826 |
| 128 | MP0008873_increased_physiological_sensi | 0.45145119 |
| 129 | MP0004264_abnormal_extraembryonic_tissu | 0.42706756 |
| 130 | MP0009672_abnormal_birth_weight | 0.41664896 |
| 131 | MP0003300_gastrointestinal_ulcer | 0.40545309 |
| 132 | MP0001845_abnormal_inflammatory_respons | 0.40534581 |
| 133 | MP0002132_abnormal_respiratory_system | 0.40239543 |
| 134 | MP0003436_decreased_susceptibility_to | 0.39246473 |
| 135 | MP0001944_abnormal_pancreas_morphology | 0.39167784 |
| 136 | MP0002135_abnormal_kidney_morphology | 0.36447519 |
| 137 | MP0000639_abnormal_adrenal_gland | 0.36116252 |
| 138 | MP0005395_other_phenotype | 0.35862715 |
| 139 | MP0003221_abnormal_cardiomyocyte_apopto | 0.34109843 |
| 140 | MP0003329_amyloid_beta_deposits | 0.33758110 |
| 141 | MP0004782_abnormal_surfactant_physiolog | 0.33527478 |
| 142 | MP0000249_abnormal_blood_vessel | 0.32270335 |
| 143 | MP0003959_abnormal_lean_body | 0.32144758 |
| 144 | MP0005375_adipose_tissue_phenotype | 0.31944520 |
| 145 | MP0003075_altered_response_to | 0.30903535 |
| 146 | MP0004185_abnormal_adipocyte_glucose | 0.29244671 |
| 147 | MP0002796_impaired_skin_barrier | 0.29112658 |
| 148 | MP0005385_cardiovascular_system_phenoty | 0.28739440 |
| 149 | MP0001544_abnormal_cardiovascular_syste | 0.28739440 |
| 150 | MP0001243_abnormal_dermal_layer | 0.28399650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.59394186 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.13579721 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.79694852 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.67250095 |
| 5 | Xanthomatosis (HP:0000991) | 5.43916810 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.24865444 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.07616783 |
| 8 | Hypoglycemic coma (HP:0001325) | 4.86301456 |
| 9 | Hyperammonemia (HP:0001987) | 4.73726352 |
| 10 | Ketosis (HP:0001946) | 4.71036242 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.52044891 |
| 12 | Hyperglycinuria (HP:0003108) | 4.48971768 |
| 13 | Hyperglycinemia (HP:0002154) | 4.24839784 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.22152574 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 4.22152574 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.14937028 |
| 17 | Complement deficiency (HP:0004431) | 4.14402270 |
| 18 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.13846295 |
| 19 | Ketoacidosis (HP:0001993) | 4.02524452 |
| 20 | Hypolipoproteinemia (HP:0010981) | 3.99695666 |
| 21 | Abnormality of glycolipid metabolism (HP:0010969) | 3.95562707 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.95562707 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.95562707 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.86910686 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.78946332 |
| 26 | Joint hemorrhage (HP:0005261) | 3.72312169 |
| 27 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.68146373 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.66322442 |
| 29 | Abnormality of the common coagulation pathway (HP:0010990) | 3.66031825 |
| 30 | Epidermoid cyst (HP:0200040) | 3.62426425 |
| 31 | Abnormality of methionine metabolism (HP:0010901) | 3.54924612 |
| 32 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.53970723 |
| 33 | Dicarboxylic aciduria (HP:0003215) | 3.53970723 |
| 34 | Hypoalphalipoproteinemia (HP:0003233) | 3.51753984 |
| 35 | Fat malabsorption (HP:0002630) | 3.51123508 |
| 36 | Generalized aminoaciduria (HP:0002909) | 3.49781294 |
| 37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.40873325 |
| 38 | Abnormality of the intrinsic pathway (HP:0010989) | 3.32613749 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.30408585 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.27415800 |
| 41 | Gout (HP:0001997) | 3.24787308 |
| 42 | Abnormality of purine metabolism (HP:0004352) | 3.20687038 |
| 43 | Metabolic acidosis (HP:0001942) | 3.12722285 |
| 44 | Purpura (HP:0000979) | 3.11787018 |
| 45 | Delayed CNS myelination (HP:0002188) | 3.11328126 |
| 46 | Abnormality of serum amino acid levels (HP:0003112) | 3.06657685 |
| 47 | Recurrent abscess formation (HP:0002722) | 3.05631079 |
| 48 | Abnormality of complement system (HP:0005339) | 3.04659332 |
| 49 | Lethargy (HP:0001254) | 3.00001302 |
| 50 | Hypercholesterolemia (HP:0003124) | 2.99474867 |
| 51 | Cerebral edema (HP:0002181) | 2.96165468 |
| 52 | Conjugated hyperbilirubinemia (HP:0002908) | 2.90916551 |
| 53 | Reduced antithrombin III activity (HP:0001976) | 2.89683951 |
| 54 | Prolonged neonatal jaundice (HP:0006579) | 2.89556212 |
| 55 | Proximal tubulopathy (HP:0000114) | 2.82011467 |
| 56 | Vacuolated lymphocytes (HP:0001922) | 2.80783650 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.79941227 |
| 58 | Late onset (HP:0003584) | 2.79664980 |
| 59 | Hypoglycemic seizures (HP:0002173) | 2.78201345 |
| 60 | Dysostosis multiplex (HP:0000943) | 2.77991209 |
| 61 | Increased intramyocellular lipid droplets (HP:0012240) | 2.70667086 |
| 62 | Recurrent bacterial skin infections (HP:0005406) | 2.70621899 |
| 63 | Hepatocellular carcinoma (HP:0001402) | 2.69700212 |
| 64 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.69232353 |
| 65 | Petechiae (HP:0000967) | 2.64518518 |
| 66 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.64340942 |
| 67 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.64340942 |
| 68 | Obstructive lung disease (HP:0006536) | 2.60323066 |
| 69 | Chronic obstructive pulmonary disease (HP:0006510) | 2.60323066 |
| 70 | Steatorrhea (HP:0002570) | 2.60008964 |
| 71 | Abnormality of macrophages (HP:0004311) | 2.56868030 |
| 72 | Vomiting (HP:0002013) | 2.54814936 |
| 73 | Abnormality of urine glucose concentration (HP:0011016) | 2.53833120 |
| 74 | Glycosuria (HP:0003076) | 2.53833120 |
| 75 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.52415088 |
| 76 | Glomerulonephritis (HP:0000099) | 2.51782017 |
| 77 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.51580845 |
| 78 | Hepatic necrosis (HP:0002605) | 2.47954360 |
| 79 | Skin nodule (HP:0200036) | 2.46278077 |
| 80 | Increased serum ferritin (HP:0003281) | 2.43420239 |
| 81 | Vertebral compression fractures (HP:0002953) | 2.42917861 |
| 82 | Eczematoid dermatitis (HP:0000976) | 2.41041587 |
| 83 | Type I transferrin isoform profile (HP:0003642) | 2.40735614 |
| 84 | Nausea (HP:0002018) | 2.40603946 |
| 85 | Vascular calcification (HP:0004934) | 2.40298119 |
| 86 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.35983445 |
| 87 | Progressive neurologic deterioration (HP:0002344) | 2.35560279 |
| 88 | Spastic diplegia (HP:0001264) | 2.34712170 |
| 89 | Increased purine levels (HP:0004368) | 2.34256003 |
| 90 | Hyperuricemia (HP:0002149) | 2.34256003 |
| 91 | Myoglobinuria (HP:0002913) | 2.32280585 |
| 92 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.31696521 |
| 93 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.31696521 |
| 94 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.31696521 |
| 95 | Malnutrition (HP:0004395) | 2.30154442 |
| 96 | Cerebral palsy (HP:0100021) | 2.27560580 |
| 97 | Irritability (HP:0000737) | 2.27083478 |
| 98 | Abnormal gallbladder morphology (HP:0012437) | 2.27058087 |
| 99 | Hepatocellular necrosis (HP:0001404) | 2.26687134 |
| 100 | Neonatal onset (HP:0003623) | 2.25594107 |
| 101 | Myocardial infarction (HP:0001658) | 2.24122706 |
| 102 | Cholelithiasis (HP:0001081) | 2.23585634 |
| 103 | Acanthocytosis (HP:0001927) | 2.22461808 |
| 104 | Systemic lupus erythematosus (HP:0002725) | 2.21876913 |
| 105 | Pancreatitis (HP:0001733) | 2.21137564 |
| 106 | Amyloidosis (HP:0011034) | 2.21103261 |
| 107 | Mitochondrial inheritance (HP:0001427) | 2.20512379 |
| 108 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.19174761 |
| 109 | Mucopolysacchariduria (HP:0008155) | 2.18395602 |
| 110 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.18395602 |
| 111 | Hydroxyprolinuria (HP:0003080) | 2.17483133 |
| 112 | Abnormality of proline metabolism (HP:0010907) | 2.17483133 |
| 113 | Hepatosplenomegaly (HP:0001433) | 2.17263976 |
| 114 | Renal cortical cysts (HP:0000803) | 2.17254575 |
| 115 | Mediastinal lymphadenopathy (HP:0100721) | 2.14011066 |
| 116 | Cardiovascular calcification (HP:0011915) | 2.13742001 |
| 117 | Opisthotonus (HP:0002179) | 2.12728025 |
| 118 | Alkalosis (HP:0001948) | 2.11696234 |
| 119 | Loss of speech (HP:0002371) | 2.11509089 |
| 120 | Spontaneous abortion (HP:0005268) | 2.11500957 |
| 121 | Brushfield spots (HP:0001088) | 2.09279045 |
| 122 | Abnormal cartilage morphology (HP:0002763) | 2.08917958 |
| 123 | Myositis (HP:0100614) | 2.07595089 |
| 124 | Lactic acidosis (HP:0003128) | 2.07411378 |
| 125 | Increased serum pyruvate (HP:0003542) | 2.06820373 |
| 126 | Acute encephalopathy (HP:0006846) | 2.05944717 |
| 127 | Renal Fanconi syndrome (HP:0001994) | 2.05249244 |
| 128 | Polygenic inheritance (HP:0010982) | 2.05076719 |
| 129 | Symptomatic seizures (HP:0011145) | 2.03193451 |
| 130 | Sensorimotor neuropathy (HP:0007141) | 2.01437065 |
| 131 | Axonal loss (HP:0003447) | 2.01414445 |
| 132 | Increased muscle lipid content (HP:0009058) | 2.01229371 |
| 133 | Mitral stenosis (HP:0001718) | 2.01061405 |
| 134 | Abnormality of iron homeostasis (HP:0011031) | 2.00869450 |
| 135 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.00747527 |
| 136 | Cholecystitis (HP:0001082) | 2.00198809 |
| 137 | Abnormal gallbladder physiology (HP:0012438) | 2.00198809 |
| 138 | Abnormal protein glycosylation (HP:0012346) | 1.98642504 |
| 139 | Abnormal glycosylation (HP:0012345) | 1.98642504 |
| 140 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.98642504 |
| 141 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.98642504 |
| 142 | Enlarged kidneys (HP:0000105) | 1.98188922 |
| 143 | Abnormality of glycolysis (HP:0004366) | 1.96195221 |
| 144 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.96034118 |
| 145 | Hypochromic microcytic anemia (HP:0004840) | 1.95590473 |
| 146 | Rhabdomyolysis (HP:0003201) | 1.93999124 |
| 147 | Gingival bleeding (HP:0000225) | 1.93098273 |
| 148 | Poikilocytosis (HP:0004447) | 1.91223675 |
| 149 | Elevated hepatic transaminases (HP:0002910) | 1.90721127 |
| 150 | Meningitis (HP:0001287) | 1.87909244 |
| 151 | Bulbar palsy (HP:0001283) | 1.87762233 |
| 152 | Hypertensive crisis (HP:0100735) | 1.87356749 |
| 153 | Ragged-red muscle fibers (HP:0003200) | 1.86576132 |
| 154 | Acute hepatic failure (HP:0006554) | 1.86146717 |
| 155 | Abnormality of the gallbladder (HP:0005264) | 1.85965802 |
| 156 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.85341139 |
| 157 | Acute necrotizing encephalopathy (HP:0006965) | 1.84109736 |
| 158 | Stomatitis (HP:0010280) | 1.83482459 |
| 159 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.82214537 |
| 160 | Increased CSF lactate (HP:0002490) | 1.81699768 |
| 161 | Microvesicular hepatic steatosis (HP:0001414) | 1.78121816 |
| 162 | Respiratory failure (HP:0002878) | 1.76897802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.48491998 |
| 2 | ERN1 | 4.19830453 |
| 3 | VRK2 | 4.14942736 |
| 4 | SIK1 | 3.62786631 |
| 5 | FGFR4 | 3.45610614 |
| 6 | TRIB3 | 2.85364181 |
| 7 | INSRR | 2.78965556 |
| 8 | SMG1 | 2.61173810 |
| 9 | FLT3 | 2.49835218 |
| 10 | PKN2 | 2.48808721 |
| 11 | TESK1 | 2.19540308 |
| 12 | TAOK3 | 2.11670913 |
| 13 | NME2 | 1.79877975 |
| 14 | MST1R | 1.75896583 |
| 15 | KDR | 1.75720026 |
| 16 | WNK4 | 1.69448994 |
| 17 | TYK2 | 1.69061389 |
| 18 | MAPK11 | 1.67568670 |
| 19 | PDK3 | 1.54669751 |
| 20 | PDK4 | 1.54669751 |
| 21 | PIK3CG | 1.54034256 |
| 22 | ARAF | 1.51201952 |
| 23 | NEK1 | 1.45358987 |
| 24 | MAP2K3 | 1.42377885 |
| 25 | ERBB4 | 1.40340732 |
| 26 | MAP3K10 | 1.39725474 |
| 27 | SCYL2 | 1.38298894 |
| 28 | NEK9 | 1.38249492 |
| 29 | ABL2 | 1.35069425 |
| 30 | MAP3K11 | 1.30604977 |
| 31 | PTK6 | 1.27564621 |
| 32 | IKBKB | 1.22895086 |
| 33 | TBK1 | 1.22565049 |
| 34 | MAP3K3 | 1.19762643 |
| 35 | PINK1 | 1.19658234 |
| 36 | MAP4K2 | 1.17523968 |
| 37 | LIMK1 | 1.12438486 |
| 38 | MYLK | 1.05918729 |
| 39 | TAF1 | 1.03382199 |
| 40 | EIF2AK1 | 1.03372613 |
| 41 | TNK2 | 1.01958542 |
| 42 | IRAK4 | 1.01036294 |
| 43 | FRK | 0.99035216 |
| 44 | JAK2 | 0.98463676 |
| 45 | MAPK15 | 0.98206950 |
| 46 | DAPK1 | 0.95642541 |
| 47 | STK38L | 0.95378071 |
| 48 | DYRK1B | 0.94488785 |
| 49 | TIE1 | 0.92988217 |
| 50 | GRK6 | 0.91828296 |
| 51 | PRKAA2 | 0.90846085 |
| 52 | GRK7 | 0.90482360 |
| 53 | MAP3K1 | 0.89061956 |
| 54 | TTN | 0.86172181 |
| 55 | VRK1 | 0.84985136 |
| 56 | LATS1 | 0.82584551 |
| 57 | RIPK4 | 0.82100890 |
| 58 | MET | 0.81703464 |
| 59 | SYK | 0.80422121 |
| 60 | LRRK2 | 0.80183826 |
| 61 | MAP2K4 | 0.78085279 |
| 62 | DAPK3 | 0.77084476 |
| 63 | IRAK3 | 0.76969012 |
| 64 | MATK | 0.76095546 |
| 65 | CDK6 | 0.74487316 |
| 66 | EPHB1 | 0.73514665 |
| 67 | MAP3K7 | 0.72980904 |
| 68 | GRK5 | 0.72897360 |
| 69 | TAOK1 | 0.72450028 |
| 70 | CDK4 | 0.70954580 |
| 71 | TGFBR2 | 0.68902302 |
| 72 | CSNK1G3 | 0.68396163 |
| 73 | STK16 | 0.68143264 |
| 74 | FES | 0.67956770 |
| 75 | WNK3 | 0.67919426 |
| 76 | MAP4K1 | 0.66618177 |
| 77 | LMTK2 | 0.65050216 |
| 78 | ACVR1B | 0.64911410 |
| 79 | IRAK2 | 0.63980613 |
| 80 | MAPK4 | 0.63624703 |
| 81 | ERBB2 | 0.63113922 |
| 82 | RPS6KA4 | 0.62754515 |
| 83 | EPHA2 | 0.62722786 |
| 84 | JAK1 | 0.62392574 |
| 85 | PDK2 | 0.62101457 |
| 86 | MAP3K13 | 0.61866825 |
| 87 | MAP2K6 | 0.61198837 |
| 88 | LYN | 0.58013699 |
| 89 | PRKACG | 0.57707518 |
| 90 | PRKAA1 | 0.57187794 |
| 91 | EPHA3 | 0.56790731 |
| 92 | PRPF4B | 0.56777891 |
| 93 | MAPKAPK3 | 0.55938853 |
| 94 | BTK | 0.54676329 |
| 95 | TAOK2 | 0.54214608 |
| 96 | RIPK1 | 0.54070513 |
| 97 | PIK3CA | 0.53850337 |
| 98 | MOS | 0.53537473 |
| 99 | GSK3A | 0.52869162 |
| 100 | KIT | 0.51627049 |
| 101 | MAP2K2 | 0.50455831 |
| 102 | ZAP70 | 0.50253157 |
| 103 | CSF1R | 0.49603418 |
| 104 | PAK4 | 0.49380770 |
| 105 | OBSCN | 0.49372704 |
| 106 | MAP3K5 | 0.48560764 |
| 107 | MAPKAPK5 | 0.48035266 |
| 108 | MAP3K12 | 0.47056012 |
| 109 | RPS6KB2 | 0.46269073 |
| 110 | MAPK12 | 0.45636269 |
| 111 | CDK9 | 0.45615939 |
| 112 | IKBKE | 0.43893438 |
| 113 | TLK1 | 0.42990670 |
| 114 | PRKCZ | 0.41032770 |
| 115 | ILK | 0.40784171 |
| 116 | CSNK1A1L | 0.40742914 |
| 117 | CDK19 | 0.40261603 |
| 118 | MAPKAPK2 | 0.39770130 |
| 119 | PASK | 0.39729617 |
| 120 | DAPK2 | 0.39404909 |
| 121 | CSK | 0.37900480 |
| 122 | LCK | 0.36850903 |
| 123 | OXSR1 | 0.36820860 |
| 124 | CAMK1D | 0.36551035 |
| 125 | TXK | 0.36337058 |
| 126 | PTK2 | 0.35913933 |
| 127 | PDPK1 | 0.35702027 |
| 128 | TESK2 | 0.35557891 |
| 129 | HCK | 0.35429749 |
| 130 | STK4 | 0.35375581 |
| 131 | RPS6KA5 | 0.35090937 |
| 132 | RPS6KC1 | 0.34130548 |
| 133 | RPS6KL1 | 0.34130548 |
| 134 | ITK | 0.32823825 |
| 135 | PRKD2 | 0.32561033 |
| 136 | PRKCD | 0.32468652 |
| 137 | CAMK2G | 0.32448428 |
| 138 | HIPK2 | 0.32337508 |
| 139 | BLK | 0.32181422 |
| 140 | PIM2 | 0.31707162 |
| 141 | PRKG2 | 0.30897239 |
| 142 | MAP2K1 | 0.30773143 |
| 143 | MAP3K8 | 0.30635017 |
| 144 | JAK3 | 0.30411936 |
| 145 | MTOR | 0.29409957 |
| 146 | MAP3K14 | 0.29042004 |
| 147 | TGFBR1 | 0.28839111 |
| 148 | TEC | 0.28586250 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.87135280 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.27113889 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.98301389 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.89676625 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.81564613 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.80949189 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.78379777 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73063263 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.56277989 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.50016687 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.48780779 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.37865832 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.34178428 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.32132914 |
| 15 | * Peroxisome_Homo sapiens_hsa04146 | 2.14490880 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.13434231 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.11235419 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.05764212 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.97839411 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88437175 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83177253 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.79238397 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.77471180 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75123761 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73674709 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.72870729 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.71372500 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69838740 |
| 29 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.64789251 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.59913900 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56190765 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.56025507 |
| 33 | Lysosome_Homo sapiens_hsa04142 | 1.55671556 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.55451108 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.54760203 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.52717637 |
| 37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.52061366 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49204701 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47865242 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.47336880 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.41834543 |
| 42 | Proteasome_Homo sapiens_hsa03050 | 1.40962835 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.34807076 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34565140 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34222002 |
| 46 | Allograft rejection_Homo sapiens_hsa05330 | 1.33075189 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.32908033 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.30724666 |
| 49 | * Retinol metabolism_Homo sapiens_hsa00830 | 1.30233201 |
| 50 | Ribosome_Homo sapiens_hsa03010 | 1.29322731 |
| 51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.29177346 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 1.29102216 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.25926793 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20117504 |
| 55 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.16734450 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.13910452 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13792759 |
| 58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.10926926 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09877462 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.07945193 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 1.04320897 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 1.03768772 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00247235 |
| 64 | Leishmaniasis_Homo sapiens_hsa05140 | 0.99330131 |
| 65 | Base excision repair_Homo sapiens_hsa03410 | 0.98507944 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.94583990 |
| 67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91741814 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.91199182 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90886331 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89805446 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.87331583 |
| 72 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.85526736 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85523353 |
| 74 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.81066437 |
| 75 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.81058704 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80501552 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.80371232 |
| 78 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79716848 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72040586 |
| 80 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71230396 |
| 81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67360400 |
| 82 | Tuberculosis_Homo sapiens_hsa05152 | 0.65471094 |
| 83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.62008250 |
| 84 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60388162 |
| 85 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.59812983 |
| 86 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57871819 |
| 87 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.57293256 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54821954 |
| 89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50169350 |
| 90 | DNA replication_Homo sapiens_hsa03030 | 0.47588919 |
| 91 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.47162705 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46958773 |
| 93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46686906 |
| 94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46654468 |
| 95 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.45701794 |
| 96 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44780831 |
| 97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43857224 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.43805498 |
| 99 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.42120943 |
| 100 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40087598 |
| 101 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40081523 |
| 102 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.39046623 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.28408191 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26803115 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24074874 |
| 106 | Parkinsons disease_Homo sapiens_hsa05012 | 0.19236161 |
| 107 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.19173253 |
| 108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15765748 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13773165 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.11105870 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09870855 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08941622 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06437764 |
| 114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.02434716 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.01731613 |
| 116 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.01722155 |
| 117 | Protein export_Homo sapiens_hsa03060 | 0.00064041 |
| 118 | Bladder cancer_Homo sapiens_hsa05219 | -0.1713722 |
| 119 | Legionellosis_Homo sapiens_hsa05134 | -0.1503866 |
| 120 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1468562 |
| 121 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1227874 |
| 122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1200507 |
| 123 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0966657 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0950095 |
| 125 | Huntingtons disease_Homo sapiens_hsa05016 | -0.0942739 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0814470 |
| 127 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.0764929 |
| 128 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0639115 |
| 129 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0592414 |
| 130 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0089388 |
| 131 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0067807 |

